FABBRI, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 6.284
AS - Asia 3.845
EU - Europa 1.779
SA - Sud America 616
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 111
OC - Oceania 17
Totale 12.802
Nazione #
US - Stati Uniti d'America 6.116
SG - Singapore 1.359
CN - Cina 984
BR - Brasile 486
VN - Vietnam 445
DE - Germania 323
UA - Ucraina 317
HK - Hong Kong 309
IT - Italia 260
TR - Turchia 210
GB - Regno Unito 181
FI - Finlandia 161
BD - Bangladesh 127
FR - Francia 113
SE - Svezia 110
RU - Federazione Russa 100
JP - Giappone 95
IN - India 74
ID - Indonesia 71
CA - Canada 69
MX - Messico 67
PL - Polonia 48
ZA - Sudafrica 41
AR - Argentina 39
IQ - Iraq 29
AT - Austria 28
ES - Italia 28
NL - Olanda 26
VE - Venezuela 21
EC - Ecuador 20
PK - Pakistan 17
AU - Australia 16
CZ - Repubblica Ceca 16
MA - Marocco 16
LT - Lituania 15
KE - Kenya 14
SA - Arabia Saudita 14
CO - Colombia 13
CL - Cile 12
DZ - Algeria 12
PY - Paraguay 12
PH - Filippine 11
JM - Giamaica 10
MY - Malesia 10
EG - Egitto 9
KR - Corea 9
UZ - Uzbekistan 9
CH - Svizzera 8
JO - Giordania 8
BE - Belgio 7
IL - Israele 6
IR - Iran 6
LB - Libano 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
AZ - Azerbaigian 5
GT - Guatemala 5
IE - Irlanda 5
KZ - Kazakistan 5
PT - Portogallo 5
RO - Romania 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
DK - Danimarca 4
UY - Uruguay 4
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
HN - Honduras 3
NP - Nepal 3
OM - Oman 3
RS - Serbia 3
TG - Togo 3
BG - Bulgaria 2
CG - Congo 2
GR - Grecia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NI - Nicaragua 2
QA - Qatar 2
SN - Senegal 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MT - Malta 1
Totale 12.645
Città #
Singapore 874
Ashburn 701
Fairfield 473
Woodbridge 437
San Jose 430
Santa Clara 339
Jacksonville 304
Hong Kong 302
Beijing 301
Houston 279
Chandler 267
Ann Arbor 189
Wilmington 176
Cambridge 172
Los Angeles 160
Seattle 159
Ho Chi Minh City 153
Council Bluffs 139
Izmir 131
New York 106
Nanjing 99
Hanoi 96
Princeton 92
Tokyo 92
Munich 83
Lauterbourg 79
Helsinki 75
Dallas 72
Buffalo 61
Milan 55
Jakarta 53
São Paulo 51
Mexico City 50
Shanghai 49
Warsaw 43
San Diego 39
Boardman 37
Addison 35
Hefei 35
Tianjin 35
Orem 33
Hebei 31
Nanchang 31
Da Nang 27
Turku 27
Denver 26
Changsha 25
Shenyang 25
Chennai 24
Jiaxing 24
Chicago 23
London 22
Bremen 21
Rio de Janeiro 21
Toronto 21
Vienna 21
Dong Ket 20
Johannesburg 20
Montreal 20
Moscow 18
San Mateo 18
Brooklyn 17
Frankfurt am Main 17
Norwalk 17
Nuremberg 17
Atlanta 16
Baghdad 16
Haiphong 15
Boston 14
Curitiba 14
Falkenstein 14
Phoenix 14
Rome 14
San Francisco 14
Washington 14
Brasília 12
Dearborn 12
Guangzhou 12
Nairobi 12
Poplar 12
Redwood City 11
Ankara 10
Belo Horizonte 10
Brno 10
Campinas 10
Ferrara 10
Hangzhou 10
Manchester 10
Ningbo 10
Philadelphia 10
Can Tho 9
Charlotte 9
Jinan 9
Krasnodar 9
Mountain View 9
Sydney 9
Taizhou 9
Dhaka 8
Falls Church 8
Jeddah 8
Totale 8.282
Nome #
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 247
CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease 246
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 237
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 234
Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis 214
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 208
Enfisema polmonare: prospettive di terapia 200
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 200
CD-4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren's syndrome 200
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 199
Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC 195
Airway smooth muscle biochemistry and asthma 192
The distribution of Neurokinin-1 and Neurokinin-2 receptors in human central airways 191
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 190
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 185
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 184
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal 184
Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement 183
Helicobacter pylori and chronic bronchitis 180
Asthma progression and mortality: The role of inhaled corticosteroids 180
Inflammatory cells in the bronchial glands of smokers with chronic bronchitis 178
Increased xanthine oxidase activity in broncoalveolar lavage fluid from subject with chronic bronchitis 175
Inhaled corticosteroids in COPD: Friend or foe? 174
Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis 170
Increased bronchial responsiveness in primary and secondary Sjogren's syndrome 169
Anti-inflammatory treatments for asthma: Past, present, future 168
Oxygen radical production of broncho-alveolar lavage fluid (BALF) from subjects with chronic bronchitis. 168
Expression of monocyte chemoattractant protein-1 (MCP-1) and CC chemokine receptor 2 (CCR2B) by purified blood monocytes in smokers with lung cancer. 167
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 164
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD 164
Differential expression of heme oxygenase (HO)-1 in macrophages of lung tumour and tumour-free lung tissues 164
Increased oxidant-induced clastogenic activity in bronchoalveolar lavage fluid obtained from subjects with chronic bronchitis. 163
Altri problemi di patologia respiratoria 162
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 161
Significant correlation between interleukin-10 expression and progression of non-small cell lung cancer through heme oxygenase 159
Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease 159
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease 157
Blood eosinophils for the management of COPD patients? 154
Current controversies in chronic obstructive pulmonary disease: A report from the global initiative for chronic obstructive lung disease scientific committee 153
Integrin expression on neutrophils and mononuclear cells in blood and induced sputum in stable asthma 152
Inhaled corticosteroid containing combinations and mortality in COPD 149
Prevention of Chronic Obstructive Pulmonary Disease 148
Production of superoxide radicals by bronchoalveolar lavage fluid obteined from patients with chronic bronchitis 145
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact 144
Immunization and challenge with toulene diisocyanate decrease tachykinin and calcitonin gene-related peptide immunoreactivity in guinea pig central airways 141
Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study 141
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 140
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 140
Sonicated serum damages human lymphocyte DNA: a model of free radicals induced cell injury 139
What can we learn from late-onset and occupational asthma? 139
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 139
Xanthine oxidase in broncho-alveolar lavage fluid of subjects with chronic bronchitis. 138
Espression of vasoactive intestinal peptide 1 receptor (VIPR1) in the central airways of smokers 138
Mechanism of occupational asthma 133
Chronic cough in adults 133
Neutrophils and asthma. 128
Severity of airflow limitation is associated with severity of airway inflammation in smokers 127
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation 126
COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer. Eur Resp J 2003; 22 Supp.45: 361s. 123
Substance P and neurokinin-A in induced sputum from patients with chronic obstructive pulmonary disease. 122
Very low density lipoproteins mediate DNA damage induced by sonicated serum on human lymphocytes. 121
Extrafine beclometasone dipropionate/ formoterol fumarate vs double bronchodilation therapy in patients with copd: A historical real-world non-inferiority study 121
Management of chronic refractory cough in adults 121
Similarities between mechanism of superoxide production in ultrasuond treated human serum and in BALF from patients with chronic bronchitis 120
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 120
A person-centred clinical approach to the multimorbid patient with COPD 115
Glucocorticoidi 115
Neutrophils and Asthma 113
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations 113
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA 113
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease 112
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice 106
Guidelines and recommendations for the clinical use of bronchoalveolar lavage in asthma 106
HLA class II molecules and asthma induced by toleune diisocyanate 105
Evaluation by self-monitoring and noninvasive measures 104
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients 103
Influence of asbestos exposure on heme oxygenase(HO)-1 expression in lung tumour-associated macrophages. 169 (7): A411. 101
Small airway dysfunction: not so silent after all? 98
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study 95
Inhaled long-acting muscarinic antagonists in asthma - A narrative review 92
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS 78
Sex differences in asthma control, lung function and exacerbations: the ATLANTIS study 76
Rate of Decline of FEV1 as Biomarker of Survival? 73
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases 72
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseases 71
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS Cohort 52
null 50
null 45
Detecting Small Airways Dysfunction in Asthma: Rationale, Findings, and Future of ATLANTIS 19
The ROME COPD exacerbation proposal works! Time to move forward 9
Totale 12.802
Categoria #
all - tutte 62.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.847
Totale 64.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022797 28 53 49 61 61 25 25 46 36 55 71 287
2022/2023646 78 16 40 79 115 86 36 59 74 3 41 19
2023/2024391 42 48 20 15 25 54 13 25 15 5 11 118
2024/20251.796 38 59 155 47 238 161 29 61 282 224 272 230
2025/20265.465 568 223 437 662 784 358 645 286 538 562 275 127
2026/2027149 149 0 0 0 0 0 0 0 0 0 0 0
Totale 12.802